Showing posts with label buyers. Show all posts
Showing posts with label buyers. Show all posts

Monday, November 21, 2011

EBITDA and Pharmacy Acquisitions in North Dakota

By Brad MacLiver
Authorship and profile at Google

EBITDA is an acronym for earnings before interest, taxes, depreciation and amortization and is often used to measure the value of some businesses. It can also be used in the comparison of similar companies.

Generally, EBITDA makes it easier to evaluate various companies and to compare them against industry averages by removing the non-core and irregular operating costs, such as interest, which can vary depending on the management’s choice of financing, taxes which can fluctuate depending on acquisitions or losses from prior years, and arbitrary factors of depreciation and amortization.

The EBITDA formula can be used as a guideline when valuing larger companies, or when comparing the profitability of large similar companies in the same industry.

For the effective use of EBITDA, these larger companies should possess significant assets, have heavy amortization schedules, or bear substantial amounts of debt. Considering independent pharmacies in North Dakota don’t meet that criteria, this formula is not a useful measure as the sole means for valuing pharmacies for acquisition purposes.

EBITDA is derived by: 1. First calculating net income by obtaining total income and subtract total expenses.
2. Determining the total amount of taxes paid to local, federal, and state governments.
3. Establishing interest fees paid to individuals or companies for the use of credit or capital.
4. Determining depreciation expenses, which are expenses recorded to allocate a tangible asset's cost over its useful life.
5. Calculating amortization expenses, which are expenses for the consumption of the value of intangible assets over a specific period of time or the asset's expected life.  These assets include goodwill, copyrights, and patents.
6. Add the values from #1 through #5.

EBITDA calculation example:

1. Net Income            2,050
2. + Taxes paid            610
3. + Interest Expenses     407
4. + Depreciation          240
5. + Amortization          102
6. = EBITDA              3,409

There are some drawbacks to EBITDA: 1. The number can be misleading when it is confused with cash flow.
2. It can also make even completely unprofitable firms appear to be financially healthy.
3. It it too easy to manipulate the numbers.
4. This value can overlook cash requirements for growth in accounts receivable.
5. It can also miss cash requirements for growth in inventories.
6. When valuing small companies, EBITDA is not factual number.
7. This number is ineffective for companies with few assets, small amounts of debt, or low depreciation or amortization schedules.


In the past, EBITDA was used as a proxy for cash flow in leveraged buyouts to calculate whether companies could service their debt. Factoring out interest, taxes, depreciation, and amortization can allow an unprofitable business to appear financially healthy. This method of valuation was used extensively during the dotcom era to value unprofitable businesses, with few assets, little earnings, and the results from that method caused many to go bust. This was a blaring example of misapplying EBITDA.

Knowledgeable North Dakota pharmacy specialists performing pharmacy business valuations will use EBITDA in pharmacy valuations, but only as part of a larger formula when computing values for specialty pharmacies in North Dakota especially those who have a niche in HIV, disease management, long term care, etc. However, EBITDA should not be used as part of the usual formula for standard retail pharmacy acquisitions.

The EBITDA number for a specific existing North Dakota pharmacy is important, for the most part, when the existing ownership is establishing their store value for the purpose of a line of credit, borrowing, creating a Trust, stock values, etc., but EBITDA does not have the same importance when selling a pharmacy. This is due to the fact the buyer will not have the same expenses as the seller.

Buyers may not have the same tax base, interest expense, or the same depreciation schedule, thus it is important that the buyer calculate an estimated EBITDA that is specific to their operating model, business systems, buying power, cost of operations, etc., not the sellers. It should also be noted that EBITDA assumes that the buyer will acquire all of the assets, working capital, accounts receivable, and liabilities. Those assumptions do not hold true regarding an acquisition of a pharmacy in North Dakota. Instead of the EBITDA number, ND pharmacy buyers should be focusing on sales, gross profit, cash flow, and customer mix.

************************

Monday, October 3, 2011

Pharmacy Industry: Current Market Conditions in North Dakota

By Brad MacLiver
Authorship and profile at Google

There are currently there are a number of factors making an impact on the current market conditions of the U.S. pharmacy industry. These factors are affecting the pharmacy business valuations of pharmacies in ND and drug stores all across the U.S.

Local Market Conditions:

The valuation process also includes local demographics and local market conditions. There is less potential for growth in smaller communities and with the declining profits, a buyer must purchase at a lower value because they will need to service the debt from a business loan while still trying to make a living. This is also the case for a community that has lost population due to economic conditions, or currently has a high rate of unemployment. Fewer people means fewer customers with the ability to purchase, which then means reduced sales and a smaller chance of any substantial improvement in the near term. This results in a lower pharmacy business value.

North Dakota Pharmacists Shortage:

Pharmacies in North Dakota and across the country have had difficulties in finding pharmacists.  This shortage of pharmacists not only affects employee opportunities it also affects the number of potential independent buyers. 

Fewer Buyers:

There are also fewer corporate buyers. Some of the largest pharmacy chains have been purchased and consolidated in the pharmacy industry roll up. Many smaller chains have run into financial difficulties and have stopped their expansion. It is more difficult to drive a price higher when there are fewer willing, or capable, to purchase.

Current Market Conditions Requires Industry Roll-up:

The consolidation of the pharmacy industry is required to get more traffic into a single store.  Due to simple economics, when any business has a reduction in profits they are less attractive to a buyer and pharmacy business values drop. There are many factors contributing to the downward pressure of pharmacy values and there is not any expectation of a turn around. Pharmacy owners should not be fooled by inexperienced Brokers claiming grand outcomes and over stating North Dakota pharmacy business values not based on realistic market conditions.

With the consolidation of the pharmacy industry that has been happening for several years, many new brokers have entered the market to broker pharmacy acquisitions. Most brokers do not have pharmacy related experience, nor do they use current market conditions when they value a pharmacy. Most are using simple accounting formulas that hold no sound reasoning for the value when faced with current North Dakota pharmacy market conditions. Due to this many brokers are valuing pharmacies 2 to 3 times more than what the market is really willing to pay. Any inexperienced person can quote a high value to capture a listing.  However, that does not mean the over inflated asking price is what the business will actually sell for.

Mail Order:

Some insurance companies are designating a noticeable amount of pharmacy patients as “long-term medications” and require they only purchase the medications from mail order ND pharmacy companies who provide products at lower prices. This results in local pharmacies not only missing out on prescription sales, but front-end sales will also decline since the customer is not entering the store. Pharmacy mail order sales have now surpassed sales from independent retail pharmacies.

Choose a firm that provides pharmacy business valuations based on real market conditions and does not use a simple formula for calculating the value of a North Dakota pharmacy. Complex methods are used to derive the value of a pharmacy.

It is best to use a company that specializes in pharmacy and has extensive and current industry data.  Choose pharmacy specialists who have been working in the pharmacy industry long enough to have extensive pharmacy experience in North Dakota and an excellent reputation.  A company with good credentials possesses large amounts of national data.  The largest financial institutions, national chain pharmacies, regional pharmacy chains, independently owned drug stores, and pharmacy equity investment groups use the services of companies fitting this description.



************************